Pharmaceuticals - Diversified
Spectrum Pharmaceuticals Inc Announces Additional Extension Of Tender Offer Period For Shares Of Allos Therapeutics, Inc.
Spectrum Pharmaceuticals Inc and Allos Therapeutics, Inc. announced that Spectrum has provided an additional extension of the offer period in connection with tender offer to purchase all of the outstanding shares of common stock of Allos for $1.82 per share in cash, without interest and less any...
FDA Approves Sanofi SA's and Regeneron Pharmaceuticals Inc's Zaltrap for Metastatic Colorectal Cancer-Reuters
Reuters reported that the U.S. Food and Drug Administration has approved Sanofi SA's and Regeneron Pharmaceuticals Inc's Zaltrap for use in combination with a folinic acid, fluorouracil and irinotecan chemotherapy regimen to treat adults with colorectal cancer.
Glaxosmithkline Plc announced that it has completed its acquisition of Human Genome Sciences for USD3.6 billion on an equity basis, or approximately USD3 billion net of cash and debt. All outstanding shares of HGS were acquired for USD14.25 per share in cash. Pursuant to the terms of the merger...
Glenmark Pharmaceuticals Ltd announced that Mr. Gracias Saldanha, Founder and Chairman Emeritus of the Company passed away on July 21, 2012.
Restructuring & Reorganization
No related earnings announcements are currently scheduled within the next 7 days.